SAPTALIS PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at SAPTALIS PHARMACEUTICALS is $75,816, based on 30 certified filings from FY 2020 to FY 2026. This is 37% lower than the national H-1B median salary of $120,000. Compensation at SAPTALIS PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $60,902 and senior positions reaching $109,034 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at SAPTALIS PHARMACEUTICALS range from $59,197 at the 10th percentile to $109,034 at the 90th percentile, showing a $49,837 spread across experience levels and roles. The 25th percentile is $60,902 and the 75th percentile is $85,946.

Yes, SAPTALIS PHARMACEUTICALS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 30 H-1B labor condition applications from FY 2020 to FY 2026, demonstrating ongoing commitment to hiring international talent. With 30 certified applications and a 0% denial rate, SAPTALIS PHARMACEUTICALS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), SAPTALIS PHARMACEUTICALS filed 1 H-1B applications, with 1 certified and 0 denied. Over 7 years of data, SAPTALIS PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

SAPTALIS PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 30 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating SAPTALIS PHARMACEUTICALS as a potential H-1B sponsor.

This is an excellent approval rate, indicating SAPTALIS PHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

SAPTALIS PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 30 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles SAPTALIS PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at SAPTALIS PHARMACEUTICALS:

The most frequently sponsored role is Associate Analytical Chemist with 5 filings at a median salary of $60,902. This is followed by Regulatory Affairs Associate (3 filings) and Senior Research Scientist.

SAPTALIS PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where SAPTALIS PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top SAPTALIS PHARMACEUTICALS H-1B locations:

The largest H-1B hub for SAPTALIS PHARMACEUTICALS is Hauppauge, NY with 30 filings at a median salary of $75,816.

SAPTALIS PHARMACEUTICALS's median H-1B salary has increased by +7% from FY 2020 ($84,000) to FY 2026 ($89,772). Tracking salary trends over time reveals how SAPTALIS PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at SAPTALIS PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2022: $105,000 (3 certified)
• FY 2023: $61,963 (4 certified)
• FY 2024: $60,000 (7 certified)
• FY 2025: $75,816 (7 certified)
• FY 2026: $89,772 (1 certified)

SAPTALIS PHARMACEUTICALS has maintained steady salary growth for H-1B positions over this period.

SAPTALIS PHARMACEUTICALS primarily files H-1B applications at Wage Level I, accounting for 53% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making SAPTALIS PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

A significant portion of SAPTALIS PHARMACEUTICALS's H-1B filings are at entry-level (Level I) wages. These positions may face more competition in the H-1B lottery.

SAPTALIS PHARMACEUTICALS's median H-1B salary of $75,816 is 37% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating SAPTALIS PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare SAPTALIS PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

SAPTALIS PHARMACEUTICALS's H-1B salaries are below the national median, though this may vary significantly by role, experience level, and location. Consider researching specific positions for more accurate compensation expectations.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. SAPTALIS PHARMACEUTICALS files 53% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 30 certified filings, SAPTALIS PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.